摘要
目的:为临床合理用药提供参考。方法:随机抽取我院2014年每月5 d住院患者口服片剂医嘱,对口服片剂分劈使用情况进行统计分析。结果:抽取医嘱涉及片剂共220个品规,分劈使用93个,占比42.27%;其中表面刻有分劈划痕52个,占比55.91%。片剂医嘱共357 602条,分劈医嘱15 202条,分劈使用率为4.25%。分劈使用率前3位的药品为多巴丝肼片、地高辛片、氯硝西泮片。结论:为了满足临床的治疗需要,片剂分劈使用有其存在的合理性,但需要药师加强与医师沟通,权衡利弊使用。
OBJECTIVE： To provide reference for clinical rational drug use. METHODS： The medical orders of oral tablet in the inpatients collected from our hospital in 2014, and the application of oral tablet splitting was analyzed statistically. RESULTS： There were 220 specifications in total, and 93 tablets were split for use, accounting for 42.27%. Of all split tablets, there were 52 kinds with split mark on surface, accounting for 55.91%. There were 357 602 medical orders of tablet and 15 202 of tablet split- ting, accounting for 4.25%. The top three categories in frequency of splitting were Benserazide tablets, Digoxin and Clonazepam tablet. CONCLUSIONS： To meet the demand of clinical treatment, tablet splitting has its rationality. It is necessary to enhance com- munication among pharmacists, doctors and nurses to weigh the pros and cons before treatment.
出处
《中国药房》
CAS
北大核心
2015年第32期4488-4490,共3页
China Pharmacy
关键词
住院患者
片剂
分劈
合理用药
Inpatient
Tablet
Splitting
Reasonable drug use
